GFI highlights chicken-and-egg conundrum facing cultivated meat industry
How will cultivated meat transition from a loss-making novelty served at a handful of restaurants to a viable alternative to animal ag?
How will cultivated meat transition from a loss-making novelty served at a handful of restaurants to a viable alternative to animal ag?
Berkeley-based Orbillion reckons it can achieve economic production for cell-cultured Wagyu beef “at around 2,000 liters in scale,” says cofounder and CEO Dr. Patricia Bubner.
“It is more likely than not that a CRISPR-enabled cell line will ultimately be necessary [for profitable production at scale],” says Eat Just CEO Josh Tetrick.
Less than five months after announcing its first commercial-scale cultivated meat plant in Glenview, Illinois, UPSIDE Foods has hit pause…
Funding for cultivated meat peaked at $989m in 2021, dipped slightly to $807m in 2022, then dropped sharply to just $177m in 2023.
The ‘PROFUSE-B8’ bovine myoblasts—muscle progenitor cells—are spontaneously immortalized without the use of genetic engineering.
We’re kidding ourselves if we think we can make the unit economics add up for cultivated meat without deploying ‘much much larger’ bioreactors, says Ark Biotech.
What’s the most efficient production platform for growth factors, pricey proteins used to stimulate cell growth and differentiation in cultivated meat?
Cultivated meat startup Omeat has emerged from stealth armed with $40m to fund a novel approach to making meat from animal cells.
UPSIDE Foods and GOOD Meat will be the first to launch cultivated meat in the US after clearing the final hurdles required by regulators.
UK-based Higher Steaks has rebranded as Uncommon and raised $30m in a series A round to scale production of cultivated pork using technology it claims gives it a competitive edge by speeding up the cell differentiation process.
Five or six years ago the press coverage around cultivated meat was almost universally positive. Today, we’re seeing headlines about cancerous cells, ‘vaporware,’ and business failures. So where does the industry go from here?
Some commentators argue that cultivated meat is a food tech fantasy. So are they right? It all depends on your approach, says Joshua March, cofounder and CEO at San Leandro-based startup SciFi Foods.
Dutch startup Meatable has slashed production times for cultivated pork from three weeks to eight days in the past year by dramatically speeding up the process by which its stem cells differentiate into fat and muscle, transforming its unit economics.
Dutch cultivated meat startup Mosa Meat has opened a new 30,000sq ft ‘scale-up plant’ in Maastricht as it edges closer to commercialization.
Israeli startup Ever After Foods (formerly Plurinuva) has unveiled technology it claims can transform the unit economics of cultivated meat by reducing the capex required to build facilities and increasing the productivity of tissue production.
Israeli startup Aleph Farms has struck deals enabling it to take an “asset-light” approach to scaling up cultivated meat production in Israel and Singapore. CEO Didier Toubia tells AFN Aleph is also scouting for sites in the US for a larger scale facility and believes it can achieve cost parity with premium beef by 2028.
The longtime entrepreneur describes the realities of founding a cultivated meat company, and offers insights for other founders and CEOs in the space.
Cell lines for cultivated meat R&D are proving hard to come by. But don’t point the finger of blame at startups, as a major UK newspaper appeared to do this week.
Ramping up production capacity is the top priority for GOOD Meat as Eat Just CEO says regulatory approval is less of a hurdle.